跳至主要内容
临床试验/CTRI/2013/10/004116
CTRI/2013/10/004116招募中2 期

Validation of Unani Pharmacopoeial formulation in Kasrat- e- Ratubat-e-Hamoozi (Hyperacidity)

Central Council for Research in Unani Medicine CCRUM New Delhi3 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2011年2月11日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
300
试验地点
3
主要终点
Improvement in signs and symptoms

研究概览

简要总结

This study is designed as a multicentric open trial in patients with Kasrat- e- Ratubat-e-Hamoozi  (hyperacidity). After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria. The patients will be assessed clinically on each fortnightly follow up. This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 06 weeks. . Laboratory parameters for safety assessment will be conducted at baseline and end of study.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Subjects in the Age group of 18-60 years •Subjects of both sexes •Subjects presenting with the following symptoms : oRetrosternal burning oEpigastric pain with retrosternal heaviness oAcidic brash oAnorexia oNausea oVomiting oPain relieved after vomiting.

排除标准

  • •Duodenal ulcer •Peptic ulcer •H/o previous gastric surgery •Presence of cardiac & lung diseases •Pregnancy/lactation •Alcoholism •Diabetes •Stomach carcinoma •Crohn’s Diseases •Allergy/Intolerance to any ingredients of the drug1,9,
  • •Zollinger Ellison Syndrome.

结局指标

主要结局

Improvement in signs and symptoms

时间窗: 6 WEEKS

次要结局

  • Outcome TimePoints(Hematological and biochemical assessments for safety)

研究者

发起方
Central Council for Research in Unani Medicine CCRUM New Delhi
申办方类型
Research institution

研究点 (3)

Loading locations...

相似试验